Please use this identifier to cite or link to this item:
https://islhd.intersearch.com.au/islhdjspui/handle/1/6161
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tierney Michael | - |
dc.date.accessioned | 2024-04-03T02:24:47Z | - |
dc.date.available | 2024-04-03T02:24:47Z | - |
dc.date.issued | 2024-03-20 | - |
dc.identifier.uri | https://islhd.intersearch.com.au/islhdjspui/handle/1/6161 | - |
dc.description | Orsiro is a stent platform that has ultrathin struts and a bioabsorbable polymer. As such it is theorised to have low late stent thrombosis rates. BIOSTEMI (the orsiro STEMI trial) has just published its 5 year results. We did Oriso for all STEMI from 2019-2022 Dec and hence have near 5 year follow up. Retrospective review of all STEMI | en |
dc.subject | Medicine | - |
dc.subject | Cardiology | - |
dc.title | Orsiro DES - real-life comparison to 5 year trial data | - |
dc.contributor.islhd | Tierney, Michael | - |
local.contributor.leadinvestigator | Michael Tierney | - |
local.contributor.contactname | Michael Tierney | - |
local.description.timecommitment | 3 months. 4 hours per week | - |
local.identifier.joblevel | JMO x2 | - |
local.subject.specificskills | None | - |
local.subject.specifictasks | Data collection | - |
local.subject.specifictasks | Data analysis and interpretation | - |
local.subject.specifictasks | Create Abstract for ANZET 2025 - due March 2025 | - |
local.identifier.status | Open | - |
local.contributor.contactemail | michael.tierney@health.nsw.gov.au | - |
Appears in Collections: | Projects |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.